Jonathan M. Nugent, VP Corporate Communications at BIOCRYST PHARMACEUTICALS INC (BCRX), sold 5,600 shares at $10.15 ($57K) on 2006-09-01, disclosed to the SEC on 2006-09-05.
Scheduled sale ($57k) by VP Corporate Communications under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.15 | 2,664 | $27K | 47.4% |
| 2 | $10.20 | 700 | $7K | 12.5% |
| 3 | $10.22 | 340 | $3K | 6.1% |
| 4 | $10.25 | 1,896 | $19K | 34.0% |
| Total | $10.19 avg | 5,600 | $57K | 100% |
| Filing → |